Clinical TrialsSearch results
Number of results: 319
Recruiting
- Observational Study on New MR Biomarkers for Alzheimer's Disease and Real-World Survey on Lecanemab Treatment in a Super-Aged Society
- Mild Alzheimer's disease
- Nakajima Takashi
- 2024-05-28
Other
- Randomized study of Taxane vs TS-1 in metastatic or recurrent breast cancer patients
- Metastatic or recurrent breast cancer
- SELECT BC executive committee
- 2006-06-01
Other
- Randomized phase III study of FOLFOX plus bevacizumab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer
- metastatic colorectal cancer
- West Japan Oncology Group
- 2008-09-26
Other
- Phase II study of a combination of CPT-11 and S-1 and bevacizumab in patients with metastatic colon cancer.
- metastatic colorectal cancer
- Niigata Colorectal cancer Chemotherapy Study Group (NCCSG)
- 2009-01-14
Other
- Gamma knife treatment results for patients with multiple brain metastases: A multi-institutional prospective study
- Metastatic brain tumor
- Japan Leksell Gamma Knife Society
- 2009-03-30
Other
- Multicenter study for combined therapy of prednisolone and mizoribine in idiopathic membranous nephropathy with refractory nephrotic syndrome
- membranous nephropathy with primary steroid resistant nephrotic syndrome
- Project team for treatment of refractory nephrotic syndrome
- 2006-03-27
Other
- Multicenter study for combined therapy of prednisolone and cyclosporin in refractory nephrotic syndrome
- membranouos nephropathy and focal segmental glomerulosclerosis with primary steroid resistant nephrotic syndrome
- Project team for treatment of refractory nephrotic syndrome
- 2006-03-27
Other
- Adjuvant MK-7684A vs Pembrolizumab for Resected High-Risk Melanoma
- Melanoma
- Koh Yasuhiro
- 2023-05-27
Other
- Phase II clinical trials of mature B-cell neoplasms in children: A Japanese Cooperative Studies
- mature B-cell non-Hodgkin's lymphoa
- Japanese Pediatric Leukemia/Lymphoma Studu Group(JPLSG)
- 2006-02-05
Other
- A multi institutional phase II study of oral fludarabine and rituximab (F-R therapy) for patients with relapsed or refractory mantle cell lymphoma.
- Mantle cell lymphoma
- Hematological Malignancy Clinical Study Group
- 2008-10-11